1 – 10 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
- Anti-phospholipid antibodies and renal involvement are the main features associated with adverse pregnancy outcomes in patients with Systemic Lupus Erythematosus. A long-term longitudinal study in Southern Sweden
- Adverse Pregnancy Outcomes after Multi-Professional Follow-Up of Women with Systemic Lupus Erythematosus : An Observational Study from a Single Centre in Sweden
- Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus
-
Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE
Nived, Ola LU ; Ingvarsson, Ragnar Freyr LU
; Jöud, Anna
LU
; Linge, Petrus
LU
; Tydén, Helena
LU
; Jönsen, Andreas
LU
and Bengtsson, Anders A
LU
(2020)
In Lupus science & medicine
7.
Mark
- Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus
- Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study : CSF/s-T4 associated with QoL in hypothyroidism
-
Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment - a distinct inflammatory pattern for oligoarticular juvenile arthritis
Schmidt, Tobias LU ; Berthold, Elisabet LU ; Arve-Butler, Sabine LU
; Gullstrand, Birgitta
LU
; Mossberg, Anki
LU
; Kahn, Fredrik
LU
; Bengtsson, Anders
LU
; Månsson, Bengt
LU
and Kahn, Robin
LU
(2020)
In Arthritis Research & Therapy
22.
Mark
- High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus
- Autoantibody and cytokine profiles during treatment with belimumab in patients with systemic lupus erythematosus